Marinello, A., Rotow, J. K., Lomibao, M., Leporati, R., Feng, J., Metro, G., Brandão, M., Nassar, A., Citarella, F., Planchard, D., Mezquita, L., Besse, B., Drilon, A. E., Aldea, M. (2025). Rechallenge with first-generation RET inhibitors in
            <i>RET</i>
            -rearranged NSCLC pre-treated with selpercatinib or pralsetinib: Results from the RET MAP registry.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8646